Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

New compounds may soon be tested to treat excessive hair growth in women.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.